The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 5, 2026 | Lang James Paul | Director | Grant(A) | 90K | — | $0 |
| Jan 5, 2026 | Lang James Paul | Director | Grant(A) | 331K | — | $0 |
| Jan 5, 2026 | Chappell Amy Suzon | Director | Grant(A) | 58K | — | $0 |
| Jan 5, 2026 | Farag Kameel D. | Director | Grant(A) | 58K | — | $0 |
| Jan 5, 2026 | Sherman Michael Edward | Director | Grant(A) | 341K | — | $0 |
| Jan 5, 2026 | Sherman Michael Edward | Director | Grant(A) | 80K | — | $0 |
| Jan 5, 2026 | Do Cuong V | President & CEO, Director | Grant(A) | 665K | — | $0 |
| Jan 5, 2026 | Rogich Sigmund | Director | Grant(A) | 141K | — | $0 |
| Jan 5, 2026 | Rogich Sigmund | Director | Grant(A) | 70K | — | $0 |
| Jan 5, 2026 | Kim Joanne Wendy | Chief Financial Officer | Grant(A) | 110K | — | $0 |
| Jan 5, 2026 | Palumbo Joseph M | Chief Medical Officer | Grant(A) | 132K | — | $0 |
| Aug 7, 2025 | Do Cuong V | President & CEO, Director | Buy(P) | 5K | — | — |
| Aug 7, 2025 | Do Cuong V | President & CEO, Director | Buy(P) | 5K | — | — |
| Dec 20, 2024 | Do Cuong V | President & CEO, Director | Grant(A) | 105K | — | $0 |
| Dec 20, 2024 | Kim Joanne Wendy | Chief Financial Officer | Grant(A) | 14K | — | $0 |
| Dec 20, 2024 | Palumbo Joseph M | Chief Medical Officer | Grant(A) | 15K | — | $0 |
| Dec 20, 2024 | Hariri Robert J | Director | Grant(A) | 22K | — | $0 |
| Dec 20, 2024 | Lang James Paul | Director | Grant(A) | 23K | — | $0 |
| Dec 20, 2024 | Sherman Michael Edward | Director | Grant(A) | 23K | — | $0 |
| Dec 20, 2024 | Berman Richard J | Director | Grant(A) | 23K | — | $0 |
| Dec 20, 2024 | Rogich Sigmund | Director | Grant(A) | 22K | — | $0 |
| Nov 20, 2024 | Hariri Robert J | Director | Grant(A) | 50K | — | $0 |
| Nov 20, 2024 | Lang James Paul | Director | Grant(A) | 62K | — | $0 |
| Nov 20, 2024 | Sherman Michael Edward | Director | Grant(A) | 57K | — | $0 |
| Nov 20, 2024 | Berman Richard J | Director | Grant(A) | 34K | — | $0 |
| Nov 20, 2024 | Rogich Sigmund | Director | Grant(A) | 33K | — | $0 |
| Jun 24, 2024 | Do Cuong V | President & CEO, Director | Grant(A) | 168K | — | $0 |
| Jun 24, 2024 | Do Cuong V | President & CEO, Director | Tax withholding(F) | 42K | $0.47 | $20K |
| Jun 24, 2024 | Do Cuong V | President & CEO, Director | Grant(A) | 227K | — | $0 |
| Jun 24, 2024 | Kim Joanne Wendy | Chief Financial Officer | Tax withholding(F) | 18K | $0.47 | $9K |
| Jun 24, 2024 | Kim Joanne Wendy | Chief Financial Officer | Grant(A) | 73K | — | $0 |
| Jun 24, 2024 | Kim Joanne Wendy | Chief Financial Officer | Grant(A) | 99K | — | $0 |
| Jun 24, 2024 | Palumbo Joseph M | Chief Medical Officer | Tax withholding(F) | 29K | $0.47 | $14K |
| Jun 24, 2024 | Palumbo Joseph M | Chief Medical Officer | Grant(A) | 116K | — | $0 |
| Jun 24, 2024 | Palumbo Joseph M | Chief Medical Officer | Grant(A) | 156K | — | $0 |
| Mar 4, 2024 | Do Cuong V | President & CEO, Director | Buy(P) | 10K | — | — |
| Mar 4, 2024 | Do Cuong V | President & CEO, Director | Buy(P) | 5K | — | — |
| Feb 15, 2024 | Do Cuong V | President & CEO, Director | Tax withholding(F) | 5K | $1.18 | $6K |
| Feb 15, 2024 | Kim Joanne Wendy | Chief Financial Officer | Tax withholding(F) | 2K | $1.18 | $3K |
| Feb 15, 2024 | Palumbo Joseph M | Chief Medical Officer | Tax withholding(F) | 2K | $1.18 | $3K |
| Dec 11, 2023 | Kim Joanne Wendy | Chief Financial Officer | Grant(A) | 5K | — | $0 |
| Dec 1, 2023 | Gorlin Steve | Director | Sell(S) | 76K | $1.69 | $128K |
| Nov 30, 2023 | Do Cuong V | President & CEO, Director | Buy(P) | 10K | $1.78 | $18K |
| Nov 9, 2023 | Berman Richard J | Director | Grant(A) | 52K | — | $0 |
| Nov 9, 2023 | Sherman Michael Edward | Director | Grant(A) | 90K | — | $0 |
| Nov 9, 2023 | Hariri Robert J | Director | Grant(A) | 42K | — | $0 |
| Nov 9, 2023 | Rogich Sigmund | Director | Grant(A) | 42K | — | $0 |
| Nov 9, 2023 | Gorlin Steve | Director | Grant(A) | 46K | — | $0 |
| Nov 9, 2023 | Lang James Paul | Director | Grant(A) | 94K | — | $0 |
| Sep 5, 2023 | Gorlin Steve | Director | Sell(S) | 9K | $3.05 | $26K |
| Aug 22, 2023 | Berman Richard J | Director | Sell(S) | 11K | $3.50 | $38K |
| Jun 29, 2023 | Do Cuong V | CEO & President, Director | Grant(A) | 150K | — | $0 |
| Jun 29, 2023 | Do Cuong V | CEO & President, Director | Grant(A) | 175K | — | $0 |
| Jun 21, 2023 | Do Cuong V | CEO & President, Director | Option exercise(M) | 42K | — | — |
| Jun 21, 2023 | Do Cuong V | CEO & President, Director | Option exercise(M) | 42K | — | $0 |
| Jun 7, 2023 | Palumbo Joseph M | Chief Medical Officer | Grant(A) | 30K | — | $0 |
| Jun 7, 2023 | Kim Joanne Wendy | Chief Financial Officer | Grant(A) | 20K | — | $0 |
| Jun 7, 2023 | Berman Richard J | Director | Sell(S) | 6K | $5.81 | $35K |
| May 22, 2023 | Berman Richard J | Director | Sell(S) | 5K | $6.50 | $33K |
| Mar 28, 2023 | Berman Richard J | Director | Sell(S) | 5K | $8.52 | $43K |
| Mar 28, 2023 | Berman Richard J | Director | Sell(S) | 3K | $8.52 | $22K |
| Mar 27, 2023 | Berman Richard J | Director | Sell(S) | 3K | $8.52 | $29K |
| Feb 16, 2023 | Do Cuong V | President & CEO, Director | Tax withholding(F) | 5K | $5.51 | $27K |
| Feb 16, 2023 | Kim Joanne Wendy | Chief Financial Officer | Tax withholding(F) | 2K | $5.51 | $14K |
| Feb 16, 2023 | Palumbo Joseph M | Chief Medical Officer | Tax withholding(F) | 2K | $5.51 | $14K |
| Feb 16, 2023 | Markham Penelope | EVP Liver Cirrhosis R&D | Tax withholding(F) | 2K | $6.12 | $15K |
| Feb 16, 2023 | Reading Christopher | EVP Neuroscience R&D | Tax withholding(F) | 2K | $6.12 | $15K |
| Feb 16, 2023 | Ahlem Clarence N. | EVP Neuroscience Product Dev. | Tax withholding(F) | 2K | $6.12 | $15K |
| Feb 16, 2023 | Do Cuong V | CEO & President, Director | Tax withholding(F) | 5K | $6.12 | $30K |
| Feb 16, 2023 | Kim Joanne Wendy | Chief Financial Officer | Tax withholding(F) | 2K | $6.12 | $15K |
| Feb 16, 2023 | Palumbo Joseph M | Chief Medical Officer | Tax withholding(F) | 2K | $6.12 | $15K |
| Nov 23, 2022 | Markham Penelope | EVP Liver Cirrhosis R&D | Grant(A) | 40K | — | $0 |
| Nov 23, 2022 | Do Cuong V | CEO & President, Director | Grant(A) | 79K | — | $0 |
| Nov 23, 2022 | Kim Joanne Wendy | Chief Financial Officer | Grant(A) | 40K | — | $0 |
| Nov 23, 2022 | Peizer Terren S | Director, 10% Owner | Grant(A) | 65K | — | $0 |
| Nov 23, 2022 | Berman Richard J | Director | Grant(A) | 44K | — | $0 |
| Nov 23, 2022 | Ahlem Clarence N. | EVP Neuroscience Product Dev. | Grant(A) | 40K | — | $0 |
| Nov 23, 2022 | Palumbo Joseph M | Chief Medical Officer | Grant(A) | 40K | — | $0 |
| Nov 23, 2022 | Hariri Robert J | Director | Grant(A) | 34K | — | $0 |
| Nov 23, 2022 | Reading Christopher | EVP Neuroscience R&D | Grant(A) | 40K | — | $0 |
| Nov 23, 2022 | Lang James Paul | Director | Grant(A) | 44K | — | $0 |
| Nov 23, 2022 | Sherman Michael Edward | Director | Grant(A) | 75K | — | $0 |
| Nov 23, 2022 | Gorlin Steve | Director | Grant(A) | 34K | — | $0 |
| Nov 23, 2022 | Rogich Sigmund | Director | Grant(A) | 55K | — | $0 |
| Aug 15, 2022 | Peizer Terren S | Director, 10% Owner | Grant(A) | 3.6M | $1.65 | $6.0M |
| Aug 15, 2022 | Peizer Terren S | Director, 10% Owner | Grant(A) | 7.3M | — | — |
| Jun 21, 2022 | Do Cuong V | President & CEO, Director | Grant(A) | 125K | — | $0 |
| Jun 21, 2022 | Do Cuong V | President & CEO, Director | Grant(A) | 125K | — | $0 |
| Apr 5, 2022 | Lang James Paul | Director | Grant(A) | 128K | — | $0 |
| Apr 5, 2022 | Rogich Sigmund | Director | Grant(A) | 123K | — | $0 |
| Apr 5, 2022 | Sherman Michael Edward | Director | Grant(A) | 130K | — | $0 |
| Apr 5, 2022 | Hariri Robert J | Director | Grant(A) | 122K | — | $0 |
| Apr 5, 2022 | Berman Richard J | Director | Grant(A) | 129K | — | $0 |
| Apr 5, 2022 | Gorlin Steve | Director | Grant(A) | 122K | — | $0 |
| Feb 2, 2022 | Adams Jonathan M | EVP Liver Cirrhosis Programs | Gift(G) | 1K | — | $0 |
| Feb 1, 2022 | Palumbo Joseph M | Chief Medical Officer | Grant(A) | 124K | — | $0 |
| Dec 31, 2021 | Do Cuong V | President & CEO, Director | Grant(A) | 22K | — | $0 |
| Dec 7, 2021 | Kim Joanne Wendy | CFO | Buy(P) | 2K | $5.40 | $11K |
| Aug 20, 2021 | Ahlem Clarence N. | EVP Neuroscience Product Dev. | Grant(A) | 124K | — | $0 |
| Aug 20, 2021 | Do Cuong V | CEO & President, Director | Grant(A) | 745K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).